SamulskiRJ, BernsKI, TanM, et al.Cloning of adeno-associated virus into pBR322: Rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A, 1982; 79(6):2077–2081; doi: 10.1073/pnas.79.6.2077
2.
HermonatPL, MuzyczkaN. Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A, 1984; 81(20):6466–6470; doi: 10.1073/pnas.81.20.6466
3.
ImDS, MuzyczkaN. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell, 1990; 61(3):447–457; doi: 10.1016/0092-8674(90)90526-k
4.
SnyderRO, SamulskiRJ, MuzyczkaN. In vitro resolution of covalently joined AAV chromosome ends. Cell, 1990; 60(1):105–113; doi: 10.1016/0092-8674(90)90720-y
5.
McCartyDM, PereiraDJ, ZolotukhinI, et al.Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol, 1994; 68(8):4988–4997; doi: 10.1128/jvi.68.8.4988-4997.1994
6.
SamulskiRJ, SrivastavaA, BernsKI, et al.Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV. Cell, 1983; 33(1):135–143; doi: 10.1016/0092-8674(83)90342-2
7.
Mechanisms of DNA Replication and Recombination. A.R. Liss: New York, NY, USA; 1983.
8.
MuzyczkaN, SamulskiRJ, HermonatP, et al.The genetics of adeno-associated virus. In: Proteins Involved in DNA Replication. Springer US: Boston, MA, USA; 1984; pp. 151–161.
9.
AshktorabH, SrivastavaA. Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol, 1989; 63(7):3034–3039; doi: 10.1128/jvi.63.7.3034-3039.1989
10.
ImDS, MuzyczkaN. Factors that bind to adeno-associated virus terminal repeats. J Virol, 1989; 63(7):3095–3104; doi: 10.1128/jvi.63.7.3095-3104.1989
11.
WangXS, PonnazhaganS, SrivastavaA. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions. J Virol, 1996; 70(3):1668–1677; doi: 10.1128/jvi.70.3.1668-1677.1996
12.
WangXS, SrivastavaA. A novel terminal resolution-like site in the adeno-associated virus type 2 genome. J Virol, 1997; 71(2):1140–1146; doi: 10.1128/jvi.71.2.1140-1146.1997
13.
WangXS, QingK, PonnazhaganS, et al.Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J Virol, 1997; 71(4):3077–3082; doi: 10.1128/jvi.71.4.3077-3082.1997
14.
ZhongL, LiB, JayandharanG, et al.Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. Virology, 2008; 381(2):194–202; doi: 10.1016/j.virol.2008.08.027
15.
ZhongL, LiB, MahCS, et al.Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci U S A, 2008; 105(22):7827–7832; doi: 10.1073/pnas.0802866105
16.
Ojano-DirainC, GlushakovaLG, ZhongL, et al.An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α. Mol Genet Metab, 2010; 101(2–3):183–191; doi: 10.1016/j.ymgme.2010.07.008
17.
LingC, WangY, LuY, et al.Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. J Virol, 2015; 89(2):952–961; doi: 10.1128/jvi.02581-14
18.
BernsKI, ByrneBJ, FlotteTR, et al.Adeno-associated virus type 2 and hepatocellular carcinoma?. Hum Gene Ther, 2015; 26(12):779–781; doi: 10.1089/hum.2015.29014.kib
